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The objective of this study was to identify and then synthesize a series of peptides 
which were able to form fibrils rich in β-sheet structure and to study the effect of the 
presence of surfaces on their formation. We decided to focus our experimental work on a 
family of peptides containing one “beta-sheet forming amino acid” and one ‘alpha-helix 
forming amino acid'. This selection covers a wide range of hydrophillicites and charges 
and, by avoiding highly hydrophobic amino acids we can assure that the diblock peptides 
are soluble in a wide range of concentrations and solvent conditions. Three different 
diblocks (20:80; 50:50 and 80:20) were synthesized. The aggregation studies were done 
in the absence and in the presence of solid/liquid interfaces. Two types of surfaces were 
used: polystyrene latexes with different surface chemistry and liposomes. The rate and 
extent of aggregation was followed by dynamic light scattering, which was used to 
monitor the size of the aggregates as a function of time. Congo Red assays were 
performed to confirm if the aggregates were amyloidic and selected samples were 
inspected by optical, scanning and atomic force microscopy. Secondary structure of the 
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SYMBOL                       DESCRIPTION 
PC Phosphatidylcholine  
PS       Phosphatidylserine  
C       Cholesterol  
PG       Phosphatidylglycerol  
PE                                   Phosphatidylethanolamine 
Ile        Isoleucine  
Lys                                  Lysine  
Glu                                 Glutamic acid 
Leu                                  Leucine 
PS                                   Polystyrene  
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PS-OH                            Polystyrene hydroxylate  
PS-COOH                      Polystyrene carboxylate 
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1. INTRODUCTION 
 
  Amyloid fibrils are proteinaceous deposits associated with a variety of human 
diseases like Alzheimer (AD), islet amyloidosis, type two diabetes, systemic amyloidosis, 
transmissible spongiform encephalopathy, Parkinson disease, familial amyloid 
polyneuropathy etc. (Sousa and Saraiva, 2003)  The impact of amyloid fibrils on human 
health is yet to be fully recognized (Dentchev et al., 2003). Amyloid diseases are 
apparently unconnected; however, intermolecular secondary structure (mostly β-sheets) is 
present in all amyloid aggregates.  Although the proteins involved in the different types 
of fibrils lack homology, the morphology of the deposits is remarkable similar (Sunde 
and Blake, 1997, Blake et al., 1996, Blake and Serpell, 1996).  Some experimental 
findings support the universality of amyloid fibrils formation (Koga et al., 2003, Sunde et 
al. 1998) whereas others contradict it (Kirschner, 1996, Inouye et al., 1993, Come et al., 
1993).  
Amyloid deposits associated with Alzheimer disease, AD, are well studied.  
Amyloid β protein residue 1-42 is the most abundant peptide found in these deposits.  An 
AMF micrograph of fibrils produced by amyloid β 1-42   obtained in this laboratory is 
shown in Figure 1.1. 
AD plaque contains advanced glycosylation end products (Muench et al., 2003ab, 
Deuther-Conrad, 2001, Loske et al., 2000, Munch et al., 1998) cooper iron (Munch et al., 
1998), amyloid Aβ(1-40), τ-protein, neuronal thread proteins, apolipoprotein E, 
glycosylated acetylcholinesterase, serum amyloid P, etc. For a review, see Mulder et al. 
(2000).  It has been suggested that some of the non-fibrillar components enhance local 
densities of fibril entanglements.(MacRaild et al., 2004) There is a lack of correlation 
between the extent of plaque formation and the severity of AD symptoms.  Current 
evidence suggests that precursors of the deposits such as oligomers and protofibrils are 
the toxic species (Chiti et al., 2006).  Most likely, toxicity is the result of a combination 




Figure 1.1.  Atomic force microscope micrograph of fibrils formed by amyloid αβ 1-




Model compounds have been used to study the formation of amyloid deposits in a 
controlled manner and to address the question:  Are all proteins capable of forming 
amyloid deposits?  There are several reports using peptides or peptides mimics.  A few of 
examples are discussed in the following paragraphs.  
Lashuel et al. (2000) used a peptidomimetic compound that self-assembles into 
polymorphic β-sheet quaternary structures, including protofilaments, filaments, fibrils, 
and ribbons that resemble the highly ordered structures displayed by the amyloidogenic 
peptides Aβ, calcitonin, and amylin.  Another example is found in the work of Kortemme 
et al. (1998) who designed a 20-residue peptide that forms amyloid type of structures.  
Banerjee et al. (2004) designed several blocked tripeptides containing aminocaproic acid 
that also form amyloid fibrils.  Koga et al. (2003) studied the self-assembly of poly(γ-
methyl-L-glutamate) grafted polyallylamine(1) in water-222-trifluorethanol and found 
that at a particular pH, salt concentration, and solvent composition the peptide forms 
fibrils rich in β-sheets. They used this evidence to suggest that the formation of fibrils is a 
universal phenomenon (i.e., it is not associated with a particular sequence).  Symmons et 
al. (1997) followed an interesting approach for the study of the structure of amyloid 
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fibrils.  They first found that a 23 amino-acid-long peptide having a single Leu-rich 
repeat polymerizes in solution yielding a β-sheet structure but a variant in which an Asn 
residue was replaced by Asp does not form fibrils.  Another variant in which Asn are 
replaced by Gln yields the β structure.  They argued that hydrogen bonding can be used 
to explain their findings.  They concluded that the tendency to forming fibrils (and β 
structure) goes beyond the known “pathogenic” proteins and extent to protein domains 
(in general).  Janek et al. (1999) used model peptides to study the influence of peptide 
length and concentration and D/L-amino acid substitution on fibril formation.  The 
problem with their approach is that all of their peptides have a central β-sheet forming 
domain; therefore, these results, because of the “bias” included in their model 
compounds, cannot be used to prove that the formation of amyloid deposits is a universal 
phenomenon. Most of the model peptides used are reasonable small (less than 30 
residues). This has important practical consequences for this work. The peptides to be 
used in this work will be prepared by solid-state synthesis whose yield decreases and the 
polydispersity of the product increases as the length of the peptide increases. 
Different chemistries and a variety of incubation conditions have been used for 
the production of fibrils using polypeptides.  For example, Hong et al. (2003) used 16-
residues peptides consisting of alternating hydrophobic (alanine) and hydrophilic (lysine 
and glutamic acid) amino acids. Peptide concentration was 0.1 mg/mL and the pH range 
was from 4 to 11. The rationale for the selection of peptides was that peptides made of 
polar and non-polar amino acids are capable of forming β sheets structures. Factors that 
affected self-assembly were amino acid sequence, concentration of peptides molecular 
size, pH, temperature and ionic strength. Giri et al. (2007) made fibrils using the 
homopeptides Ala11, Ala7 and Ala17 at pH 11 and incubated at room temperature for a 
period of 20 days. Klunk et al. (1989) used poly-L-lysine at a concentration of 10µg/mL 
at ph 11 and temperature of 50 
o
C. The incubation time was only 10 min.  They also used 
poly-L-serine at pH 7.4.  Fandrich and Dobson (2002) made fibrils using a) poly lysine at 
2.5mg/mL in water at pH 11.2 at 65C for 4 days; b) poly glutamic acid at 1 mg/mL in 
water at pH 4 at 65 C for 2 days; and c) poly threonine 10mg/mL in water at pH 9 at 65C 
for 4 days. The same peptides needed to be incubated at room temperature for period of 
six weeks to obtain fibrils. Tjernberg et al. (1998) made fibrils using a family of 
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multiblock peptides using lysine, leucine, valine, phenyl- alanine, glutamine, alanine, 
glutamic acid and aspartic acid. The peptides were dissolved in 50 mM tris buffer at pH 
7.5 and incubated at 37C for 3 days. Use of high temperatures and extreme pHs (with 
some exceptions) has been common.  The incubation time varies from a few hours to 
weeks.  Peptide concentration ranges from µg/mL to several mg/mL.  All these examples 
were taking into consideration in our experimental design.  
The effect of surfaces on the formation of the deposits remains obscure in spite of 
the large amount of published material (Giacomelli and Norde, 2003, Moores, 2011, 
Ruschak and Miranker, 2007). It is generally accepted that the effect of the presence of a 
solid/liquid interface affects the ability of peptides to form amyloid deposits and the 
mechanism of amyloid formation, particularly the nature and concentration of surfaces 
(Gorbenko and Kinnunen, 2006). Surfaces that mimic cell membranes, tissue surfaces 
and charged surfaces seems to be preferred.  Surfaces may provide nucleation sites for 
fibril formation. The concentration of amyloid peptides in healthy or sick tissue is of the 
order of a few nano-moles per liter. Therefore, the presence of a liquid/solid interface 
may serve as a crowding agent that “catalyses” the formation of the aggregates affecting 
either the thermodynamics (equilibrium) or kinetic aspects of fibril formation.  
Absorption of the peptides on the solid surface may actually decrease their concentration 
in bulk inhibiting aggregation if the concentration of peptides is not high enough.   
The primary objective of this work was to study the formation of fibrils by a 
family of diblock peptides in the presence and in the absence of solid/liquid interfaces.  
The choice of interfaces covers a range of inorganic surfaces with different surface 
chemistry and a family of liposomes with different charges and membrane fluidity.  The 
formation of fibrils was followed by several methods simultaneously because it is know 
that the use of a single method may lead to false positives.    The chosen techniques were 
a colorimetric assay, Congo Red, (Mahler et al. 200,  Klunk et al., 1989); FTIR (which is 
used to quantify the relative amounts of α helix and β sheets in proteins and protein 
aggregates); optical microscopy (to obtain some gross visual confirmation of the 
formation of fibrils); and either SEM, TEM or AFM to confirm some of the structures.   
The data is somehow fragmented because we tried to explore a very broad experimental 
data base.   
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2. MATERIALS AND METHODS 
 
2.1 MATERIALS 
Dimethylformamide (DMF) and trifluoracetic acid (TFA) were purchased from 
Acros organics, HBTU (O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-
phosphate), the FMOC protected amino acids and  the Wang resin were purchased from 
CS Bio, Menlo California, diisopropylethylamine (DIEA) was purchased from Fisher 
Scientific, ethyl ether, dichloromethane (DCM) peptide synthesis grade was purchased 
from Fisher Scientific.  99% piperidine, potassium bromide (KBr), Congo red dye, 
Calcein dye and Sephadex G-50 (bead size 20-50µm) were purchased from Sigma-
Aldrich, Saint Louis. Calcium fluoride (CaF2) Windows were purchased from 
(International Crystal Labs, Garfield, NJ). Polystyrene (PS) (diameter: 107 nm; 
concentration 2.64 w/v %), polystyrene amino (PS-NH2) (diameter: 193 nm, 
concentration: 2.63 w/v %), polystyrene hydroxylate (PS-OH) (diameter: 193 nm, 
concentration: 2.63 w/v %) and polystyrene carboxylate (PS-COOH) (diameter: 107 nm, 
concentration: 2.57 w/v %) latexes were purchased from Polysciences Inc. Warrington, 
PA. L-α- Phosphatidylcholine (PC) from egg yolk (~99% pure), L-α- Phosphatidyl-L-
serine (PS) from Glycine max (soybean), L-α-Phosphatidyl-DL-glycerol (PG), L-α- 
Phosphatidylethanolamine (PE) from egg yolk (~98% pure) and cholesterol (~99% pure) 
were purchased from Sigma (St. Louis, MO, USA). All chemicals were used as received 
without further purification. 
2.2 METHODS 
2.2.1 Peptide Synthesis.  A CS Bio 336 peptide synthesizer was used for 
synthesizing peptides. A HBTU solution was prepared by dissolving 19 g of HBTU in 
100 mL of DMF. 20% piperidine solution was prepared in DMF. 0.5 g of Wang resin was 
measured and added to the reactor. 1mmole of the desired amino acid was weighted and 
added to vials which were sealed and arranged as per required sequence into the wheel of 
the peptide synthesizer. The synthesis of a 10 residues peptide takes about 24 hr. whereas 
the synthesis of a 20 residues peptide takes 46 hours. 
 After the synthesis, the peptide was recovered from the reactor by adding 
generous amounts of DCM. The suspension was swirled and passed through a disposable 
6 
 
syringe having a filter at the other end. The residue was then dried under vacuum for 20 
minutes. The peptide was cleaved from the dried resin using a 95% TFA / 5% water 
mixture and left in a sonicator for 40 min. Crushed ice was added to the sonicator to keep 
the temperature low; sonication increased the yield of peptide by 15 to 20 %.Then the 
cleaved mixture was passed through the same filter and the filtrate was directly 
precipitated in 30 mL of ice cold diethyl ether. The precipitate was centrifuged in a 
refrigerated centrifuge (RC-3B Refrigerated centrifuge, Soverall Instruments) at 4000 
rpm, -5ºC for 30 min. The pellet was re-suspended in 20mL of fresh ether and centrifuged 
again. Then the supernatant ether was removed and the pellet was air dried under a 
laminar flow hood. The peptide was dissolved in 5mL of 0.010 M acetic acid and freeze-
dried using a Labconco freeze dry system.  
2.2.2 Liposome Preparation.  The liposomes were prepared by freeze drying (Li 
and Deng, 2004) 20 mg total of lipid (must be lower than 30 mg/mL total) was dissolved 
in 1 mL of tert-ButylAlcohol (tBA). 150 mg of sucrose (must be 7.5 times the amount of 
lipid per weight.  The addition of sucrose helps determining size) was dissolved in 1 mL 
of water.   The two solutions were mixed at a volume ratio between 1:1 and 1:2. The 
mixture should be optically clear.  To ensure proper mixing, the mixture was sonicated 
sometimes for 30 seconds. The solution was then filtered through a 0.22 µm filter into a 
10 mL vial. The sample was then freeze-dried by freezing for 8 hours and drying for as 
long as it takes to dry. After drying the sample was stored in the freezer. 
2.2.3 In Vitro Fibril Formation.  Peptides solutions were prepared at a 
concentration of 0.1 % (1mg/mL). All buffers used were filtered with Whatman 0.22 µm 
filters. Bulk peptides and peptides in the presence of various surfaces were incubated at a 
temperature of 60º C for a period of up to 12 days (Hong et al, 2003, Giri et al., 2007).  
The incubation of peptides was carried out at pH 4, 7 and 9.  0.1 % (1mg/mL) of peptide 
solutions at pH 4 and 7 were prepared and 2µL of 0.06 mg/mL of liposomes and 
2.6mg/mL of polystyrene nanosphere surfaces were added to each cuvette. Dynamic light 
scattering readings were taken in a FOQELS particle size analyzer (Brookhaven 
Instruments Corporation, Holtsville, NY).   
2.2.4 Congo Red Assay.  A stock solution of Congo red dye was made by adding 
7mg of dye to 1 mL of buffer Solution (150mM NaCl, 5mM KH2PO4, pH 7.40). A 
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Hitachi U2900 UV Spectrophotometer was used for wavelength scans. 1 mL of buffer 
was placed in a disposable cuvette and to it 5µL of Congo red dye from stock solution 
was added and the spectrum was recorded from 700nm to 300 nm. To the same cuvette 
10µL of a peptide sample which has to be tested was added and the spectrum was 
recorded again. A red shift in the peak indicates the presence of amyloid fibrils. 
2.2.5 Optical Microscopy.  Samples which were found positive in Congo red 
tests were visually analyzed in a compound microscope. A 20µL sample was placed on 
top of a glass slide and covered with a cover slip.  After 10 minutes it was viewed under 
an Olympus CKX-41 microscope. Images were taken using an Altra-20 camera. Some 
samples, which were found to be positive in Congo red, were centrifuged (Eppendorf 
5810R centrifuge) at 4000 rpm for 20 min. The pellets formed were then suspended in 
500µL of nanopure water and viewed under the microscope.  
2.2.6 Atomic Force Microscopy and Scanning Electron Microscopy.   Some 
samples were viewed using Scanning electron Microscopy (SEM) and Atomic Forced 
Microscopy (AFM). The SEM images were taken using a Hitachi S-4700 FESEM. 
Silicon wafers were cut using a diamond tipped cutter. The wafers were then cleaned 
thoroughly using the following protocol. 40 mL of 1% alconox solution was taken in a 
beaker the disks were each held & moved around 4-5 times in it with the help of sharp 
tweezers. The disks were then washed with deionised water. They were then dropped in 
5% HF solution for 3 min. and then they were taken out and swirled around 4-5 times in a 
beaker containing deionised water. The disks were allowed to dry under a laminar flow 
hood. Approximately 15 µL of sample was dried on each silicon wafer under a laminar 
flow hood. Samples for SEM were dried on silicon wafers first and then coated with a 
carbon film to make the samples conducting. The scan size of the area ranged from 
13.3µm to 1.75µm with a scan rate of 1.001 Hz. AFM imaging was carried out in tapping 
mode at room temperature. 
2.2.7 FT-IR Analysis.  Analysis of all the peptides and amyloid fibril samples 
was done in a Thermo Scientific Nicolet 6700 FTIR. IR scans of the peptides were done 
in solid state as well as in liquid state. In the solid state process 1mg of the sample to be 
analyzed was mixed with 50mg of KBr, the mixture was thoroughly crushed using a 
mortar and pestle. The powder was compressed using a press to form a pellet. The sample 
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chamber of the FTIR was purged with dry, CO2 free, air for 5 minutes before and after 
loading the sample. 16 scans were taken at a resolution of 2 cm
-1
. CaF2 windows were 
used for liquid samples. Background was collected using only the CaF2 windows. 
Approximately 20µL of sample was then dried on these windows and then IR scans was 
taken (Fandrich and Dobson, 2002; Kong and Yu, 2007; Nilsson, 2004)  
2.2.8 Dye Leakage Experiments.  Two buffers, A and B were prepared. Buffer A 
consisted of 1 mmol (142 mg) Na2HPO4 in 100 mL nanopure water and its pH was 
adjusted to 7 by adding 0.1M NaOH. Buffer B was made from 10 mmol (1.42 g) 
Na2HPO
4
 and 90 mmol (5.26 g) NaCl in 1L of nanopure water. 249 mg of calcein was 
dissolved in 10 mL of buffer A. 0.1 M NaOH was added drop by drop until calcein was 
completely dissolved and then the pH was adjusted to 7. Liposomes were hydrated in 
1mL of calcein dye. The suspension was then stirred using a magnetic stirrer for 1 hour. 
Later the suspension was subjected to five freeze-thaw cycles. During each cycle freezing 
was done using a dry ice- acetone mixture and thawing with water at room temperature. 
Then the dye loaded liposome suspension was extruded twice using a 0.45 µm Whatman 
filter. The dye filled liposomes were separated from the excess dye using size exclusion 
chromatography. A BioLogic LP chromatography system (Bio-Rad Laboratories, Inc.) 
was used with a Sephadex G-50 column (length: 30 cm, diameter: 2cm) and 10 mmol 
phosphate buffer at pH 7 containing 90 mmol NaCl as eluent.  Sample’s size was 1 mL.  
1 mL fractions were collected for the dye leakage experiments. Leakage induced by 
peptides was monitored by recording increased in intensity of calcein fluorescence.10µL 
each of peptide solution and dye filled liposomes were added to 200µL of buffer B in a 
96 well plate (Fisher Scientific). Triton-X (20% in DMF) was added to liposomes to 
measure intensity for 100% leakage. Fluorescence intensity was measured in a Fulostar 
optima fluorescent plate reader with excitation wavelength 490nm and emission 




3. RESULTS AND DISCUSSIONS 
 
To identify and then synthesize a series of peptides that form aggregates rich in β-
sheet structure will be like finding a needle in a haystack.  How long the peptides should 
be?  What amino acids should be used to build them?  Although it is known that Ala, 
Leu, Met, Phe, Glu, Gln, Lys, Arg, and His have α-helix preference whereas Tyr, Trp, Ile, 
Val, Thr, and Cys have β-sheet preference, what sequence of amino acids is the 
appropriate one? Two approaches have been followed to solve this puzzle: 1) 
identification of a particular amino acid (Tartablia et al., 2005) by the statistical analysis 
of protein sequences that form amyloid deposits (Tartablia et al., 2005) and 2) the use of 
homo-peptides (Blondelle et al., 1997). Although some particular sequences have been 
identified as β-sheet structure forming, it is impossible to say how many of those 
sequences exist.  It has also been found that homopeptides of alanine (plus two terminal 
lysines) form amyloid type of aggregates. This in spite of the fact that alanine is an amino 
acid found preferentially in α-helices and whose presence in sequences associated with 
amyloid formation is rare (Tartablia et al., 2005). The hypothesis of those using 
homopeptides is that all amino acids are able to form amyloid type of aggregates under 
the appropriate conditions. We have decided to take a pragmatic approach by using 
diblock polypeptides. We argue that diblock polypeptides resemble protein surface 
patches and thus they are better protein mimics than homopeptides or alternated block 
peptides.  We decided to focus our experimental work on a family of peptides containing 
one “β-sheet forming amino acid” (Ile) and one ‘α-helix forming amino acid’ (Glu or 
Lys).  In some experiments, Ile was replaced by leu that is an amino acid frequently 
found in α helices.  This selection covers a wide range of hydrophillicites and charges 
and, by avoiding highly hydrophobic amino acids (tryptophan or phenylalanine) we can 
assure that the diblock peptides will be soluble in a wide range of concentrations and 
solvent conditions.  Peptides were synthesized in two different lengths (10 and 20 amino 
acids) and different diblocks lengths. 
Experiments aimed at the formation of fibrils were conducted with bulk peptides 
and with peptides near solid/liquid interfaces. A list of peptides used in this work is 
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shown in Table 1.  More than one type of test was performed to assess the formation of 
amyloid type of fibrils. 
 
  
Table 3.1.  Peptides.  
(Ile)10-b-(Lys)10 (Ile)7-b-(Lys)3 (Ile)7-b-(Glu)3 (leu)7-b-(Lys)3 
(Ile)8-b-(Lys)12 (Ile)6-b-(Lys)4 (Ile)6-b-(Glu)4 (Leu)5-b-(Lys)5 
(Ile)5-b-(Lys)15 (Ile)5-b-(Lys)5 (Ile)5-b-(Glu)5  
(Ile)9-b-(Lys)1 (Ile)4-b-(Lys)6 (Leu)9-b-(Lys)1  




3.1 BULK PEPTIDES.  A preliminary screening was done with 16 different 
peptides in the absence of solid/liquid interfaces.  The peptides were all diblock peptides 
either 10 or 20 amino acids in length.  The peptides were incubated at pH 4, 7 and 9 over 
a period of up to two weeks.    
The ability of the peptides to form structures rich in β-sheet structure was 
determined by the Congo red assay.  The Congo red dye binds specifically to β-sheets 
which results in a red wavelength shift of the scans (Klunk et al., 1989).  Samples 
incubated at pH 7 and 9 did not form amyloid fibrils but some incubated at pH 4 did 
(Table 2).  The following peptides formed fibrils when incubated at pH 4:  (Ile)10-b-
(Lys)10, (Ile)5-b-(Lys)5, (Ile)8-b-(Lys)12, (Ile)7-b-(Lys)3 and (Ile)6-b-(Lys)4. A 
representative spectra-shift graph is shown in Figure 3.1.  The remaining spectra are 





Table 3.2.  Preliminary screening of fibril formation by several peptides. The 









(Ile)10-b-(Lys)10 +     
(Ile)8-b-(Lys)12 +     
(Ile)5-b-(Lys)15 -     
(Ile)9-b-(Lys)1 -   (Leu)9-b-(Lys)1 - 
(Ile)8-b-(Lys)2 -   (Leu)8-b-(Lys)2 - 
(Ile)7-b-(Lys)3 + (Ile)7-b-(Glu)3 - (leu)7-b-(Lys)3 - 
(Ile)6-b-(Lys)4 + (Ile)6-b-(Glu)4 -   
(Ile)5-b-(Lys)5 + (Ile)5-b-(Glu)5 - (Leu)5-b-(Lys)5 - 
(Ile)4-b-(Lys)6 -     




Peptides containing less than 40% (mol %) or more than 70 % Ile did not form 
fibrils.  Replacing of isoleucine by leucine (5
th
 column) and/or lysine by glutamic acid 
(3
rd
 column) inhibited the formation of fibrils.  Isoleucine is a positional isomer of 
leucine, the branching at the β-carbon tends to increase its bulkiness and thus its 
hydrophobicity. Leucine is less hydrophobic (hydrophobic index: 2.2) than isoleucine 
(hydrophobic index: 3.1) and it shows a preference for being within α-helices more so 
than in β strands. Therefore (and in spite of their subtle structural differences), it is 
somehow expected that the replacement of isoleucine by leucine may inhibit the 
formation of fibrils, as observed.  Lysine has an isoelectric point of 9 and glutamic acid 
an isoelectric point of 4 but they are both present in α helices.  Peptides containing Lys 
form fibrils at pHs away from the isoelectric point (~ 9) of the amino acid.  Therefore, we 
expected that peptides containing glutamic acid would form fibrils at basic pHs (the 
isoelectric point of the glutamic block would be ~ 4).  We did not observe that.  There is 
12 
 
some evidence (Fandrich and Dobson, 2002) that suggests that fibrils may be formed at 
pHs near the isoelectric point of homopeptides.  It seems that the behavior of diblock 




Figure 3.1.   Congo red scan for (Ile)7-b-(Lys)3in bulk. 
 
 
Table 3.3.  Shorter incubation times for selected diblock peptides.  
          Time 




















(Ile)10-b-(Lys)10 - - + + + + 
(Ile)5-b-(Lys)5 - - - - - + 
(Ile)6-b-(Lys)4 - - - - - + 
(Ile)7-b-(Lys)3 - - - - - + 


























The experiments were extended to shorter incubation times in an attempt to 
capture kinetic differences between those peptides that yield fibrils after an incubation 
time of one week.  Table 3.3 summarizes the results.  For a given length, the fibrillation 
lag time seems to be constant.  Fibrillation of longer peptides occurs faster than of shorter 
peptides (36 hrs. vs. 72 hrs. lag time).  It is worth to notice that all experiments were done 
with the same peptide concentration on a mass base.  Therefore, the concentration of the 
large peptides by mole is roughly one half the concentrations of the short peptides.  
Considering that aggregation is proportional to the number of moles of the species that 
aggregates this result is odd unless the formation of fibrils in the longer peptides is 
favored by a larger content of secondary structure.  This was tested by FTIR. 
 










Figure 3.2.   FTIR scans for upper left: (Ile)7-b-(Lys)3 , upper right: (Ile)10-b-(Lys)10  
lower left: (Ile)5-b-(Lys)15. In the upper panels the dotted line corresponds to the 
peptide before incubation and the solid lines to the peptide after incubation. The 




A single test is not sufficient to assess the formation of amyloid fibrils.  FTIR 
spectroscopy may be used to determine the secondary structure of peptides. Characteristic 
bands found in the infrared spectra of proteins and polypeptides include the Amide I and 
Amide II. The wavelengths assignments  for various secondary structures in the Amide l 
band are: (a) side chains: from 1600 to 1620 cm
-1
, (b) β sheets: from 1620 to 1640 cm-1 , 
(c) α helices: from 1645 to 1660 cm-1 , (d) random coil: from 1660 to 1680 cm-1 ,  and (e) 
β turns from 1680 to1690 cm-1. 
Figure 3.2 shows the red shift of the amide I band, which is characteristic of β 
sheet structure.  FTIR scans for peptide samples which did not show presence of amyloid 
fibrils have peaks at 1680 cm
-1
 and 1650 cm
-1
, which correspond to α helices and β turns. 
Tables 3.4 and 3.5 below show the percentage of β sheets, α helices, random coils, β 
turns and side chains in the Amide I band of the spectra of several peptides.  
 
 












(Ile)7-b-(Lys)3 49.5 3.3 5.4 32.5 9.3 
(Ile)6-b-(Lys)4 45.7 12.5 10.9 20.0 10.9 
(Ile)5-b-(Lys)5 40.6 18.0 - 37.2 4.3 
(Ile)10-b-(Lys)10 38.5 5.6 14.2 24.8 16.8 
(Ile)8-b-(Lys)12 38.1 4.0 18.4 22.6 16.1 






Table 3.5.  Secondary structure content of selected peptides after incubation for 12 
days at 60 
o












(Ile)7-b-(Lys)3 65.7 3.9 10.0 11.8 8.5 
(Ile)6-b-(Lys)4 63.4 4.9 9.2 13.0 9.4 
(Ile)5-b-(Lys)5 73.5 - 9.0 9.9 7.6 
(Ile)10-b-(Lys)10 73.4 1.7 - 15.4 9.4 
(Ile)8-b-(Lys)12 46.7 2.9 14.6 25.6 9.9 
(Ile)5-b-(Lys)15 29.4 19.7 22.5 19.1 9.3 
 
 
There is a significant increase in β-sheet content after incubation.  Also, samples 
that formed fibrils show significantly higher quantities of β sheets and β turns. For 
example, (Ile)10-b-(Lys)10 (a fibril forming peptide) contains approximately 80%  β sheets 
and β turns whereas (Ile)5-b-(Lys)15  which was negative showed low content 
(approximately 50%) of β sheets and β turns. These findings were similar to those 
reported in (Krebs et al. 2004). Notice that (Ile)5-b-(Lys)15 before incubation has a very 
low β sheet and β turn content.  Table 3.4 also shows that the shorter peptides have a 
higher β sheet and β turn but a lower random coil content than the longer peptides.  It 
seems to suggest that more disorganized peptides form fibrils more readily.  This is 
consistent with the fact that fibril formation is induced in native proteins by subjecting 
them to very harsh (denaturing) conditions.  
3.2 PEPTIDES IN THE PRESENCE OF SOLID/LIQUID INTERFACES   
Data in the presence of solid/liquid interfaces was taken after 5, 10 and 15 days.  
The pH was either 4 or 7 and the incubation temperature was 60 
o
C.  Fibrillation did not 
take place at pH 7.  The results at pH 4 are summarized in Table 3.6.  We have included 




Table 3. 6.  Formation of fibrils in the presence of solid/liquid interfaces. 
               Surfaces       
        
 
Peptides and  
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(PC=phosphatidylcholine; PS: phosphatidylserine; C: cholesterol; PG: 
phosphatidylglycerol; PE: phosphatidylethanolamine) 
 
 
The presence of a solid/liquid interface does not affect the ability of large diblock 
peptides to form fibrils.  Short peptides formation of fibrils is inhibited by both liposomes 
and latex.  In the presence of surfaces, the twenty-residues peptides (Ile)10-b-(Lys)10 and 
(Ile)8-b-(Lys)12 were found to give positive Congo red test on the fifth day whereas 10 
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chain peptides (Ile)5-b-(Lys)5, (Ile)7-b-(Lys)3 and (Ile)6-b-(Lys)4gave positive results on 
tenth day.  This is similar to the observed trend in bulk in which the shorter peptides 
showed a longer lag time. The effect of surface seems to be independent of surface 
chemistry and surface charge.  The peptides are all positively charge at pH 4.  The latex 
surface varies from a strong negative charge in the case of bare PS (isoelectric point ~ 2) 
to positively charged in the case of PS-NH2. The only common feature of the latexes is 
the fact that all decrease the available volume causing an increase in the concentration of 
the peptides; particularly in the case in which the peptide and the latexes have the same 
type of charge.   It is possible that different mechanisms are responsible for the apparent 
inhibitory effect of the latex. Liposomes containing phosphatidylethanolamine, 
phosphatidylglycerol, and phosphatidylserine inhibit the formation of fibrils.  Our 
hypothesis in the case of those surfaces which inhibited fibril formation is that the 
peptides had infused into the liposomes and therefore they are not available for 
fibrillation.  In order to conform this we carried out a series of dye leakage experiments 
in which liposomes were loaded with a fluorescent dye. 
We attempted to follow the aggregation process by dynamic light scattering.  
Measurements were done immediately after sample preparation and after 4, 8 and 12 
days.   After 8 and 12 days most of the fibrils precipitate out and therefore the data is not 
very reliable.  The complete data set is included in Appendix D.  Each experiment has 
been done in duplicate; therefore, only data for which the correlation functions of both 
samples are comparable will be discussed below.  We recognize that DLS has been used 
in the past (Mahler et al., 2008) for the monitoring of protein aggregation.  However, we 
consider that most of that data may not be reliable because of intrinsic inconsistencies 
between duplicates caused by the somehow random aggregation processes.   In the panels 
of Figures 3.3 through 3.6 we present time  correlation functions for the peptides (Ile)10-
b-(Lys)10 and (Ile)5-b-(Lys)5 after incubation in the presence of various liposomes and 
inorganic surfaces.  Blanks are also included. 
The bare latex was quite stable up to 8 days (Figure 3.3, panels e and f).  
Aggregates are present after four days for the larger peptide in PS-NH2 (panel c).  They 
are less evident for the shorter peptides (panel a).  The sharp decay shown in panel (f) 
(blank) remains unaltered for the larger peptide (panel d).  The decay is slower for the 
18 
 
smaller peptide in PS-OH (panel b).  These results are somehow at odds with the results 
from Congo red that suggest that the presence of the latex prolongs the lag time for   the 





Figure 3.3.  Aggregation of two peptides in the presence of two latexes.   (a) (Ile)5-b-
(Lys)5  in PS-NH2. (b) (Ile)5-b-(Lys)5 in PS-OH.  (c)  (Ile)10-b-(Lys)10  in PS-NH2 .  (d) 




Figure 3.4. Dynamic light scattering results for (Ile)5-b-(Lys)5 and  (Ile)10-b-(Lys)10  
in the presence of PC/C liposomes at various times.  The left panels are for PC/C 
20%/80% and the right panels are for PC/C 80%/20%.  a) b)  (Ile)5-b-(Lys)5 , c) d) 




Figure 3.5. Dynamic light scattering results for (a) (Ile)5-b-(Lys)5 and (b)  (Ile)10-b-
(Lys)10  in the presence of PC/PS liposomes at various times.  Panel (c) corresponds 
to liposome blanks.  The blanks at 4, 8 and 12 days were replotted in panel (d) to 
highlight the changes.  
 
 
Figure 3.4 shows that PC/C 20%/80% liposomes are not quite stable after four 
days whereas the PC/C 80%/20% remain reasonable unchanged after 4 days (panel f).  
Heavy aggregation is obvious for both peptides in 20%/80% liposomes.  The data for 
80%/20% liposomes seems to have a single population for the smaller peptide but two 
distinct populations for the larger peptide (panel (d)).   Figure 3.5 shows that PC/PS 
liposomes aggregate after four days in the absence of peptides.  Panel (d) clearly shows 
two populations with very distinct time constants.  The small peptide shows aggregation 
after 4 days (Panel (a)).  The large peptide shows small aggregates after 4 days and large 




Figure 3.6. Dynamic light scattering results for (Ile)5-b-(Lys)5 and  (Ile)10-b-(Lys)10  
in the presence of PC/PE/PS/C  and PC/PG/PE/C  liposomes at various times.  Left 
panels are for PC/PG/PE/C liposomes and right panels are for PC/PE/PS/C 




Both PC/PG/PE/C and PC/PE/PS/C show signs of aggregations after four days 
(panels (e) and (f) in Figure 3.6).  A comparison between panels (a) and (c) shows that 
the short peptide forms larger aggregates than that the larger peptide.  The trend seems to 






Figure 3.7.  SEM micrograph of (a) (Ile)7-b-(Lys)3 ; (b) Optical microscope image of 
(Ile)6-b-(Lys)4  (c) Optical image of (Ile)7-b-(Lys)3 and polystyrene (d) AFM image of 
(Ile)7-b-(Lys)3 (e) (Ile)7-b-(Lys)3 and polystyrene;  (f) (Ile)7-b-(Lys)3 and polystyrene. 
 
 
SEM, TEM, AFM and an optical microscope were used to visualize the presence 
of fibrils. Representative pictures are shown in Figure 3.7 and a more comprehensive 
collection is included in Appendix C. The presence of Congo red bound to the fibrils is 
also evident in some images. Images of fibrils in presence of polystyrene beads appear to 
show that polystyrene spheres aggregate and serve as the nucleation sites for fibrils. 
Panels (e) and (f) shos images of amyloid fibrils in the presence of polystyrene and 
multiple fibrils attached from a single nucleation site are visible. 
Four of the peptides that formed fibrils were checked for their ability to penetrate 





test is commonly used to detect antimicrobial activity of synthetic peptides. All the 
peptides caused leakage in all but two (PC/C 80/20 and 20/80) of the liposomes (Figures 

















































Readings were also taken after  24, 48 and 72 hours to determine if the amount of 
leakage increased after one day and if liposomes that were intact after 24 hrs show any 
leakage after further incubation. No changes were observed. Liposomes which did 
rupture in the presence of peptides resemble relatively complex biological membranes 
and have a more rigid surface because of the presence of cholesterol. It is striking that 
(Ile)5-b-(Lys)5, which has the higher helical content, is the peptide that causes the least 
leakage.  It has been speculated that one of the features of antimicrobial peptides is that 
they exist as random coils in bulk but that they form helices near lipid bilayers. The other 
three liposomes which showed leakage in the presence of peptides are known to have a 
relative fluid membrane surface. Another hypothesis is that liposomes PC/C (80/20) and 
PC/C (20/80) did not show any leakage because of a lower surface charge. Haywood and 
























We have identified a family of diblock peptides that forms amyloid fibrils at 
moderate conditions (pH 4 and 60 
o
C).  The kinetics of fibril formation seems to be 
affected by the overall length of the peptide but not by their composition (beyond some 
critical block concentrations).  Longer peptides form fibrils faster than shorter ones.  The 
addition of a variety of surfaces does not positively affect the formation of fibrils.  For 
example, the peptides are still unable to form fibrils in the presence of surfaces at neutral 
or basic pHs.  As a matter of fact, some interfaces seem to inhibit the formation of fibrils.  
Our results suggest that some surfaces (liposomes) uptake the peptides and therefore the 
actual peptide concentration available for fibrillation maybe smaller than needed.  
Another plausible explanation for the seemingly inhibitory effect of some liposomes is 
that the presence of the peptides at the incubation conditions release free phospholipids 
into the bulk fluid and this affects the solvent conditions needed for the formation of 
fibrils.  
It is obvious from this exploratory work that narrower kinetic explorations at 




















































(Ile)7-b-(Lys)3 in bulk 
           Blank 






















(Lys)10-b-(Ile)10 in PS-OH 
             Blank 





























(Lys)10-b-(Ile)10 in PS-COOH 
               Blank 




















(Lys)10-b-(Ile)10 in PS-NH2 (a) 
           Blank 



























(Lys)10-b-(Ile)10 in PS-NH2 (b) 
          Blank 




















(Lys)10-b-(Ile)10 in PS  (a) 
          Blank 





























(Lys)10-b-(Ile)10  in 80/20:PC/PS (a) 
                Blank 





















(Lys)10-b-(Ile)10  in 80/20:PC/C (a)  
          Blank 




























(Lys)10-b-(Ile)10  in 80/20:C/PC (a) 
          Blanks 
















































(Lys)10-b-(Ile)10  in 10:5:7.5:16 PC/PE/PS/C (a) 
           Blank 



















(Lys)10-b-(Ile)10  in PS (b) 
          Blank 



























(Lys)10-b-(Ile)10 in PS-OH (b) 
          Blank 



















(Ile)7-b-(Lys)3 in PS-NH2 
            Blank 

























(Lys)10-b-(Ile)10  in PS-COOH (b) 
          Blank 





















(Lys)10-b-(Ile)10  in 80/20:PC/PS  (b) 
          Blank 
























(Lys)10-b-(Ile)10  in 10:5:7.5:16 PC/PE/PS/C (b) 
          Blank 




















(Ile)5-b-(Lys)5 in bulk  
          Blanks 


























(Ile)7-b-(Lys)3 in bulk 
           Blank 



















(Ile)10-b-(Lys)10  in bulk  
          Blank 
























































































(Ile)7-b-(Lys)3 .  After incubation 
 
 
(Ile)6-b-(Lys)4.  After incubation.  
 
 
































   (Ile)6-b-(Lys)4 in bulk                       (Ile)6-b-(Lys)4 in PS                   (Ile)6-b-(Lys)4 in PS-OH 
                
 
(Ile)6-b-(Lys)4 in PS-COOH              (Ile)10-b-(Lys)10  in bulk                  (Ile)10-b-(Lys)10 in PS 
             
 
    (Ile)10-b-(Lys)10 in PS                    (Ile)10-b-(Lys)10 in PS                 (Ile)10-b-(Lys)10 in PS-OH 






(Ile)10-b-(Lys)10 in 80%/20%(PC/PS)  (Ile)10-b-(Lys)10 in 2:2:1:1C/PC/PG/PE   (Ile)5-b-(Lys)5 in bulk 
             
 
   (Ile)5-b-(Lys)5 in PS                      (Ile)5-b-(Lys)5 in PS-OH                  (Ile)5-b-(Lys)5 in bulk 
          
 
(Ile)5-b-(Lys)5 in 80%/20%(PC/C)     (Ile)5-b-(Lys)5 in 80%/20%(PC/C)     (Ile)7-b-(Lys)3 in bulk 






(Ile)7-b-(Lys)3  in PS                         (Ile)7-b-(Lys)3 in PS             (Ile)7-b-(Lys)3 in 80%/20%(PC/C) 
          
 
(Ile)7-b-(Lys)3 in 80%/20%(PC/C)     (Ile)7-b-(Lys)3 in PS-COOH          (Ile)7-b-(Lys)3 in PS-COOH 
             
 
(Ile)7-b-(Lys)3 in bulk                                                   (Ile)7-b-(Lys)3 in PS 







(Ile)7-b-(Lys)3  in bulk             (Ile)7-b-(Lys)3 in PS-OH             (Ile)7-b-(Lys)3 in 80%/20%(C/PS) 
          
 
(Ile)7-b-(Lys)3 in 80%/20%(C/PS)        (Ile)7-b-(Lys)3 in PS-NH2          (Ile)7-b-(Lys)3 in PS-NH2      
            
 
      (Ile)7-b-(Lys)3 in PS-NH2                               (Ile)7-b-(Lys)3 in bulk  dried on slide 








(Ile)7-b-(Lys)3  in bulk dried on slide 
          
 
 (Ile)8-b-(Lys)12  in bulk          (Ile)8-b-(Lys)12 in 80%/20%(PC/C)    (Ile)8-b-(Lys)12in 80%/20%(PC/C) 
               
 
     (Ile)8-b-(Lys)12 in bulk         (Ile)8-b-(Lys)12 in 10:5:7.5:16PC/PE/PS/C     (Ile)8-b-(Lys)12 in PS 























































































































































































































































































2:2:1:1  Cholesterol/PC/PG/PE 



















2:2:1:1  Cholesterol/PC/PG/PE 
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